CME Group CEO Terry Duffy: From the Trading Floor to the Future of Markets

CME Group Chairman and CEO Terry Duffy joins Market Overtime to reflect on his career, the evolution of financial markets and the future of trading. Duffy shares how he got his start on Chicago's trading floors, the lessons learned from an early-career trading mistake, and how he navigated some of the most consequential moments in market history, including the 1987 stock market crash and the 2008 financial crisis.

CME Group Brazilian Real Futures Set New Daily Volume Record Following Election

Record $9 billion notional traded, eleven times the year-to-date average daily volume (ADV) as market participants turned to CME Group to manage risk around the clock CHICAGO, Oct. 27, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its Brazilian real (BRL) futures reached a new daily volume record of 498,498 contracts (R$49.8 billion, ~$9.2 billion notional value) on October 26, surpassing the previous record of 191,325 contracts (~$3.7 billion notional value) traded on September 28, 2026. "Following the results of the Brazilian presidential election, clients turned to our BRL futures market to immediately manage their risk outside of Brazilian trading hours, driving all-time record volume," said Paul Houston, Global Head of FX Products, CME Group.

PRNewsWire • Oct 27, 2026

CME (CME) Upgraded to Buy: Here's Why

CME (CME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Oct 27, 2026

CME vs. Mastercard: Which Financial Stock Is a Better Buy in 2026?

CME Group dominates the global derivatives market with industry-leading net margins. Mastercard leverages a massive payments network to capture the ongoing shift toward digital transactions.

The Motley Fool • Oct 27, 2026

Parnassus Value Equity Fund Q3 2026 Portfolio Review

Parnassus Value Equity Fund (Investor Shares) returned -1.38% (net of fees) for the quarter, underperforming the Russell 1000 Value Index's 2.61%. Top contributors include Thermo Fisher, CME Group, NICE, Willis Towers Watson and Verizon. Bottom contributors include Cummins, Applied Materials, Brookfield Renewable, Home Depot and AstraZeneca.

Seeking Alpha • Oct 27, 2026

CME Group vs. Coinbase Global: Steady Growth Meets Crypto's Boom-and-Bust Cycle

CME currently leads Coinbase Global in revenue, as it maintains a consistent performance across recent periods while the latter company navigates a prolonged downward trend. Over roughly the last eight quarters, CME displayed mostly stable quarter-over-quarter results with a slight upward trajectory.

The Motley Fool • Oct 26, 2026

CME Group's Results Were Solid, But Not Enough To Pull The Trigger On An Upgrade

CME Group delivers strong revenue and profit growth, but valuation remains elevated, justifying my continued 'hold' rating. Q3 revenue rose 13% to $1.74B, with broad-based volume gains across all product lines, despite a slight decline in average rate per contract. Adjusted net profit margin stands at 62.4%, and net debt is minimal relative to CME's $106B+ market cap, underscoring a low risk profile.

Seeking Alpha • Oct 22, 2026

CME CEO Terry Duffy: We're seeing a record-level of participation

Terry Duffy, CME Group CEO, joins 'Power Lunch' to discuss record Q3 revenue, the future of trading, and more.

CNBC Television • Oct 21, 2026

What Will 100 Hyperliquid (HYPE) Be Worth by 2030?

Multicoin Capital just made Hyperliquid its largest hedge fund position, and a fee buyback mechanism quietly purchases HYPE every single day.

24/7 Wall Street • Oct 21, 2026

CME Group: 3 Key Takeaways for Long-Term Investors

Average daily volume reached 29.4 million contracts in the third quarter. CME Group provided clients an average $100 billion daily margin savings.

The Motley Fool • Oct 21, 2026